Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations

被引:11
|
作者
Vansickel, Andrea [1 ]
Baxter, Sarah [2 ]
Sherwood, Neil
Kong, Michael [3 ]
Campbell, Leanne [2 ]
机构
[1] Altria Client Serv LLC, Regulatory Affairs, Richmond, VA 23225 USA
[2] RAI Serv Co, Clin Studies, Winston Salem, NC USA
[3] Altasci Clin Res, Montreal, PQ, Canada
关键词
REDUCED EXPOSURE PRODUCTS; ELECTRONIC CIGARETTE; COMBUSTIBLE CIGARETTES; REINFORCING EFFICACY; INTRAVENOUS NICOTINE; DELIVERY; PHARMACOKINETICS; DISCRIMINATION; SMOKERS; VALIDATION;
D O I
10.1093/ntr/ntab183
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Many regulatory bodies now recommend that tobacco product manufacturers provide information regarding new tobacco products' abuse liability to inform regulatory authorization of currently marketed tobacco products or new product applications (including premarket tobacco product applications in the United States). In addition, the US Food and Drug Administration (FDA) recommends including this information as part of modified risk tobacco product applications. Regulators, including FDA, and many public health officials and researchers consider abuse liability assessment a model which predicts the likelihood that the use of the tobacco product would result in addiction and be used repeatedly or even sporadically resulting in undesirable effects. Abuse liability of a new, potentially reduced harm product can also inform its ability to substitute completely for more harmful tobacco products. While many methods exist, no standard tobacco product abuse liability assessment has been established. The purpose of this review is to provide background information and practical recommendations for human abuse liability testing methods to meet tobacco regulatory needs. A combination of nicotine test product pharmacokinetic, subjective effect and/or behavioral response, and physiological response data relative to comparator products with known abuse liability satisfies some regulatory requirements. Implications: This review provides a practical inspection of the current, international regulatory recommendations for abuse liability assessment of tobacco and regulatory review of such information within the United States and also recommends study designs and methods for abuse liability testing of tobacco products based on scientific and regulatory knowledge. Given that tobacco product abuse liability testing is of increasing interest to regulatory bodies globally, especially with the emergence of novel tobacco products, this timely work provides background and functional recommendations for tobacco product abuse liability testing.
引用
收藏
页码:295 / 305
页数:11
相关论文
共 50 条
  • [21] An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy (vol 12, 14701, 2022)
    Hardie, George
    Gale, Nathan
    McEwan, Michael
    Oscar, Stefano Milleri
    Ziviani, Luigi
    Proctor, Christopher J.
    Murphy, James
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Advances in regulatory mechanism(s) and biotechnological approaches to modulate nicotine content in tobacco
    Dwivedi, Shambhavi
    Singh, Deeksha
    Singh, Nivedita
    Trivedi, Prabodh Kumar
    PLANT PHYSIOLOGY AND BIOCHEMISTRY, 2024, 207
  • [23] Recommendations for the Use of Behavioral Economic Demand as an Abuse Liability Assessment for Drug Scheduling
    Koffarnus, Mikhail N.
    POLICY INSIGHTS FROM THE BEHAVIORAL AND BRAIN SCIENCES, 2023, 10 (01) : 113 - 120
  • [24] Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
    Gaca, Marianna
    Williamson, Justine
    Digard, Helena
    Adams, Louise
    Hawkridge, Lauren
    Proctor, Christopher
    NICOTINE & TOBACCO RESEARCH, 2022, 24 (09) : 1371 - 1378
  • [25] BARCELONA MEETING ON CLINICAL-TESTING OF DRUG-ABUSE LIABILITY - CONSENSUS STATEMENT AND RECOMMENDATIONS
    不详
    BRITISH JOURNAL OF ADDICTION, 1991, 86 (12): : 1527 - 1528
  • [26] Methodological Approaches for Risk Assessment of Tobacco and Related Products
    Staal, Yvonne C. M.
    Bos, Peter M. J.
    Talhout, Reinskje
    TOXICS, 2022, 10 (09)
  • [27] Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of tobacco and other nicotine-containing products
    Miller-Holt, Jacqueline
    Behrsing, Holger P.
    Clippinger, Amy J.
    Hirn, Carole
    Stedeford, Todd J.
    Stucki, Andreas O.
    FRONTIERS IN TOXICOLOGY, 2022, 4
  • [28] Assessment of Nicotine delivery capabilities and evaluation of human health risk of metals associated with selected tobacco products
    Charles Osei-Owusu
    Opoku Gyamfi
    Edward Ankapong
    Kofi Sarpong
    Victor Agyei
    Kofi Agyapong Addo
    Nana Yaa Awua-Boateng
    Collins Kuffour
    Papa Kofi Amissah-Reynolds
    Eugene Ansah
    Enoch Bessah
    Emmanuel Dartey
    Matt Dodd
    Godfred Darko
    Discover Toxicology, 1 (1):
  • [29] Novel tobacco products, including potential reduced exposure products: research needs and regulatory recommendations
    Ashley, D. L.
    Ayo-Yusuf, O. A.
    Boobis, A. R.
    da Costa e Silva, Vera Luiza
    Djordjevic, M. V.
    Gray, N.
    Gupta, P.
    Hammond, S. K.
    Hatsukami, D.
    Henningfield, J.
    Opperhuizen, A.
    Zaatari, G.
    WHO STUDY GROUP ON TOBACCO PRODUCT REGULATION: REPORT ON THE SCIENTIFIC BASIS OF TOBACCO PRODUCT REGULATION: FIFTH REPORT OF A WHO STUDY GROUP, 2015, 989 : 17 - 30
  • [30] Dependence on Tobacco and Nicotine Products: A Case for Product-Specific Assessment
    Fagerstrom, Karl
    Eissenberg, Thomas
    NICOTINE & TOBACCO RESEARCH, 2012, 14 (11) : 1382 - 1390